Cephalon, Chiron regulatory update

The FDA's Peripheral and Central Nervous System Drugs Advisory Committee will review Myotrophin ( IGF-1) on June 7 to treat amyotrophic lateral sclerosis, prior to the filing of an NDA. The companies ...